KATHRYN OLSEN: Open Payments
NPI 1902889124 · LOVELAND, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$28,526 in 164 payments from 19 companies in 2025. Trend: 2023 $8,988 · 2024 $24,709 · 2025 $28,526
Speaker / faculty: $20,813Food & beverage: $2,707Consulting: $2,550Travel & lodging: $2,387Education: $69
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 54 | $23,592 |
| Lilly USA, LLC | 9 | $2,722 |
| UCB, Inc. | 12 | $277 |
| ABBVIE INC. | 17 | $272 |
| Galderma Laboratories, L.P. | 8 | $265 |
| E.R. Squibb & Sons, L.L.C. | 11 | $263 |
| Amgen Inc. | 8 | $215 |
| Regeneron Healthcare Solutions, Inc. | 7 | $173 |
| GENZYME CORPORATION | 6 | $147 |
| Novartis Pharmaceuticals Corporation | 7 | $143 |
Products named: TREMFYA, EBGLYSS, DUPIXENT, NEMLUVIO, Sotyktu, SKYRIZI, Bimzelx, OTEZLA.
Industry payments across CO — which companies pay providers there.
